Glyburide News
Emirates Diabetes Society Warns: Untreated diabetes can lead to serious complications and premature death
Type 2 diabetes is a chronic, progressive illness often linked to premature death, and affects approximately 230 million individuals worldwide, nearly 6 percent of the world’s adult population. The IDF (International Diabetes...
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Background The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known.
Long-term Safety of Pioglitazone versus Glyburide in Patients with Recently Diagnosed Type 2 Diabetes Mellitus
Study Objective. To evaluate the long-term safety and efficacy of glyburide versus pioglitazone in patients with a recent diagnosis of type 2 diabetes mellitus.
Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety
Gestational diabetes affects up to 5% of women. Oral hypoglycemics have been avoided because of the assumption that their placental transfer may cause fetal-neonatal hypoglycemia.
Protein may help prevent diabetes by keeping insulin-making cells alive
Diabetes researchers hoping to enlist the help of a protein targeted by cancer therapies have gained an important new insight into how the protein, known as mTOR, works in the pancreas.
Displaying results 6 to 10 out of 14